These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21397675)

  • 1. Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol.
    Wang XH; Cai LL; Zhang XY; Deng LY; Zheng H; Deng CY; Wen JL; Zhao X; Wei YQ; Chen LJ
    Int J Pharm; 2011 May; 410(1-2):169-74. PubMed ID: 21397675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, structural and in vitro studies of well-dispersed monomethoxy-poly(ethylene glycol)-honokiol conjugate micelles.
    Qiu N; Cai LL; Xie D; Wang G; Wu W; Zhang Y; Song H; Yin H; Chen L
    Biomed Mater; 2010 Dec; 5(6):065006. PubMed ID: 20966535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
    J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of PEG coating on in vitro cytotoxicity and in vivo disposition of topotecan loaded liposomes in rats.
    Dadashzadeh S; Vali AM; Rezaie M
    Int J Pharm; 2008 Apr; 353(1-2):251-9. PubMed ID: 18191511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization, pharmacokinetics, tissue distribution and antitumor activity of honokiol submicron lipid emulsions in tumor-burdened mice.
    Zheng J; Tang Y; Sun M; Zhao Y; Li Q; Zhou J; Wang Y
    Pharmazie; 2013 Jan; 68(1):41-6. PubMed ID: 23444779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of liposomal bifendate in liver following intravenous injection in mice.
    Zhipeng C; Jiabi Z; Hongxuan C; Yan-yu X; Jun C; Bao-chang C
    J Drug Target; 2010 Sep; 18(8):627-36. PubMed ID: 20166805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic honokiol delivery: I. Preparation and characterization.
    Gong C; Wei X; Wang X; Wang Y; Guo G; Mao Y; Luo F; Qian Z
    Nanotechnology; 2010 May; 21(21):215103. PubMed ID: 20431208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Honokiol nanosuspensions: preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system.
    Han M; Yu X; Guo Y; Wang Y; Kuang H; Wang X
    Colloids Surf B Biointerfaces; 2014 Apr; 116():114-20. PubMed ID: 24448177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome.
    Wang X; Deng L; Cai L; Zhang X; Zheng H; Deng C; Duan X; Zhao X; Wei Y; Chen L
    J Pharm Sci; 2011 Aug; 100(8):3357-3364. PubMed ID: 21387317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced pharmacokinetics and anti-tumor efficacy of PEGylated liposomal rhaponticin and plasma protein binding ability of rhaponticin.
    Sun Y; Zhao Y
    J Nanosci Nanotechnol; 2012 Oct; 12(10):7677-84. PubMed ID: 23421127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembled honokiol-loaded micelles based on poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) copolymer.
    Wei X; Gong C; Shi S; Fu S; Men K; Zeng S; Zheng X; Gou M; Chen L; Qiu L; Qian Z
    Int J Pharm; 2009 Mar; 369(1-2):170-5. PubMed ID: 19028556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models.
    Hou W; Chen L; Yang G; Zhou H; Jiang Q; Zhong Z; Hu J; Chen X; Wang X; Yuan Y; Tang M; Wen J; Wei Y
    Phytother Res; 2008 Aug; 22(8):1125-32. PubMed ID: 18570244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Micronization of magnolia bark extract by RESS as well as dissolution and pharmacokinetics evaluation].
    He S; Lei ZJ; Zhang SY; Zhang ZY
    Yao Xue Xue Bao; 2009 May; 44(5):532-9. PubMed ID: 19618732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and pharmacokinetics of nimodipine-loaded liposomes.
    Wang Z; Deng Y; Zhang X; Wang T; Wu F
    J Pharm Pharmacol; 2006 Sep; 58(9):1289-94. PubMed ID: 16945189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation of plumbagin loaded long circulating pegylated liposomes: in vivo evaluation in C57BL/6J mice bearing B16F1 melanoma.
    Kumar MR; Aithal BK; Udupa N; Reddy MS; Raakesh V; Murthy RS; Raju DP; Rao BS
    Drug Deliv; 2011; 18(7):511-22. PubMed ID: 21793763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?
    Hong RL; Huang CJ; Tseng YL; Pang VF; Chen ST; Liu JJ; Chang FH
    Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stereoselective pharmacokinetics of clausenamide enantiomers and their major metabolites after single intravenous and oral administration to rats.
    Zhu CJ; Zhang JT
    Chirality; 2003 Oct; 15(8):668-73. PubMed ID: 12923804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
    Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
    Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirolimus-loaded polymeric micelles with honokiol for oral delivery.
    Li X; Hou X; Ding W; Cong S; Zhang Y; Chen M; Meng Y; Lei J; Liu Y; Li G
    J Pharm Pharmacol; 2015 Dec; 67(12):1663-72. PubMed ID: 26454249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel honokiol liposome: formulation, pharmacokinetics, and antitumor studies.
    Zhou C; Guo C; Li W; Zhao J; Yang Q; Tan T; Wan Z; Dong J; Song X; Gong T
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2005-2012. PubMed ID: 30058387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.